BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 10451632)

  • 1. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mineralocorticoid hypertension. A new form of secondary hypertension?].
    Román O
    Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New data on hormone-dependent hypertension and their significance for the practice].
    Horký K; Petrásek J; Marek J
    Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hyperaldosteronism in hypertension].
    Girerd X
    Rev Med Suisse; 2008 Sep; 4(170):1924-6. PubMed ID: 18847121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system in primary and secondary hypertension.
    del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S
    Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
    Gilani M; Asif N; Akram A; Gilani M; Ijaz A; Malik SS
    J Pak Med Assoc; 2018 Aug; 68(8):1179-1182. PubMed ID: 30108382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressure.
    Bravo EL; Rafey MA
    J Am Coll Cardiol; 2010 May; 55(19):2181-2. PubMed ID: 20447546
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism, a common entity? the myth persists.
    Padfield PL
    J Hum Hypertens; 2002 Mar; 16(3):159-62. PubMed ID: 11896504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T; Hanon O; Mounier-Vehier C; Marquand A; Fauvel JP; Laurent P; Tison E; Equine O; Ducloux D; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1037-9. PubMed ID: 10989753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma renin activity (PRA) and plasma aldosterone in the adrenal cortex hyperactivity. Studies on 50 hypertensive patients.
    Augustin M; Dumitriu L; Ioaniţiu D; Popovici D; Gabrielescu-Berceanu A; Mănciulescu D; Marinescu I; Mazilu M; Dinulescu E; Tache A
    Endocrinologie; 1984; 22(1):37-45. PubMed ID: 6369502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid hypertension and hypokalemia.
    Khosla N; Hogan D
    Semin Nephrol; 2006 Nov; 26(6):434-40. PubMed ID: 17275580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of mineralocorticoid excess: an update for clinicians.
    Zennaro MC; Rickard AJ; Boulkroun S
    Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
    Lim PO; Jung RT; MacDonald TM
    J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.